J0701 HCPCS Level II code: Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
J0701 is the HCPCS code for “Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0701Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
Short description: Inj. cefepime hcl (baxter)
HCPCS · United States
Medicare details
The indicators CMS publishes with J0701 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2023
Where J0701 sits
- 1J codesDrugs administered other than orally
- 2Active code J0701Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0701 mean?
J0701 is the HCPCS code for “Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0701?
CMS lists J0701’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0701
All J codesJ0694Injection, cefoxitin sodium, 1 gmJ0695Injection, ceftolozane 50 mg and tazobactam 25 mgJ0696Injection, ceftriaxone sodium, per 250 mgJ0697Injection, sterile cefuroxime sodium, per 750 mgJ0698Injection, cefotaxime sodium, per gmJ0699Injection, cefiderocol, 10 mgJ0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mgJ0703Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mgJ0706Injection, caffeine citrate, 5 mgJ0710Injection, cephapirin sodium, up to 1 gmJ0712Injection, ceftaroline fosamil, 10 mgJ0713Injection, ceftazidime, per 500 mg